Chinese Association for Biomaterials 

华人生物材料协会

CAB Member News

<< First  < Prev   1   2   Next >  Last >> 
  • 12 Jan 2023 8:39 PM | Nan Zhao (Administrator)

    The CAB Global Biomaterials Leadership Award recognizes individuals who have made exceptional contributions and demonstrated global leadership in the field of biomaterials research and translation. The winner receives a cash honorarium of $2000 and a trophy. No more than two awards are given each year.

    The CAB Distinguished Leadership and Service Award recognizes an individual who has demonstrated outstanding leadership and exceptional services to the CAB community.

    The CAB Trainee/Young/Mid-Career Investigator Awards recognize individuals who have demonstrated significant achievements in the field of biomaterials research. CAB membership is required for our Chinese colleagues to receive these awards. No more than two awards are given each year for each of the three categories.

     The candidates for the CAB Trainee Award must be within 3 years of receipt of PhD degree and should not exceed the rank of Post-doctoral Fellow or equivalent.

     The candidates for the CAB Young Investigator Award must be within 10 years of receipt of PhD degree and should not exceed the rank of Assistant Professor or equivalent.

     The candidates for the CAB Mid-Career Investigator Award must carry a rank higher than Assistant Professor or equivalent and should not exceed the rank of Associate Professor or equivalent.

    Each CAB member can nominate up to two candidates. Each nomination should include a curriculum vitae of the nominee together with one nomination letter from the nominator. All nominations will be considered by the CAB Award Committee. Nomination packages should be sent to the CAB Award Committee co-chairs, Professor Ke Cheng at Ke_Cheng@unc.edu and Professor Xiaoming He at shawnhe@umd.edu by January 31, 2023. The awardees will be notified by e-mail. All the recipients will receive a plaque and be recognized at the CAB Annual Meeting during the Society for Biomaterials Annual Meeting 2023 in San Diego, USA (April 27-30, 2023).


  • 3 May 2022 6:52 PM | Malcolm Xing (Administrator)

    The unprecedent COVID-19 pandemic had interrupted all in-person conferences and meetings. Now CAB Reception and Award Ceremony for 2022 is finally back with an exciting schedule to bring you the best gathering and networking you expect from CAB. This year’s reception took place in Baltimore, MD on April 28, 2022, as a special even at the SFB annual meeting.



    More than 50 attendees from all over the world gathered together to celebrate the CAB Awards for 2022, among them, two internationally-renowned professors, Dr. Guillermo Ameer and Dr. Xuesi Chen, were the awardees of the Global Biomaterials Leadership Award.


    Moreover, a dinner at the local restaurant “Red Pepper” attended by all witnessed how close our CAB family could be. It is really exciting that our CAB family is growing every day, and we appreciate your continuous support and patriotism, so please join us in the next events sponsored by CAB.


  • 3 May 2022 10:49 AM | Malcolm Xing (Administrator)

    We are pleased to announce the winners of the CAB Awards in 2022! The CAB Global Biomaterials Leadership Award is awarded to Prof. Guillermo Ameer and Prof. Xuesi Chen to recognize their distinguished leadership in advancing the basic and translational research in biomaterials. The CAB Mid-Career, Young Investigator, and Trainee Awards go to Prof. Guohao Dai, Prof. YiZhou Dong, Prof. Xin Zhao, Prof. Guojun Chen, Prof. Yu Huang, Dr. Yang Liu, and Dr. Yuyuan Wang, respectively, for their excellent achievements in biomaterials research. Please join us to congratulate all the CAB award winners!




    Global Biomaterials Leadership Award

    • ·       Dr Guillermo Ameer (Northwestern University) 
    • ·       Dr Xuesi Chen (Chinese Academy of Sciences)


     

    Mid-Career Award

    • ·       Dr Guohao Dai (Northeastern University)
    • ·       

      • Dr Yizhou Dong (The Ohio State University)

    • Yizhou Dong
    •  Dr Xin Zhao (The Polytechnique University of Hong Kong)
    • Dr Xin Zhao

    Young Investigator Award

    • ·       Dr Guojun Chen (McGill University)
    • IMG_8354.PNG
    • ·       Dr Yu Huang (Utah State University)

    Trainee Award

    • ·       Dr Yang Liu (University of Connecticut, Storrs Campus)

    • ·       Dr Yuyuan Wang (University of Wisconsin-Madison)
    •  


  • 16 Jan 2022 7:50 PM | Anonymous

    Contact Info: Yunzhi Peter Yang, ypyang@stanford.edu

    Description:

    One postdoctoral position in bone biology and/or stem cell biology is available immediately in the lab of Professor Yunzhi Peter Yang, Departments of Orthopedic Surgery at Stanford University at https://med.stanford.edu/yanglab.html. The candidates with strong biology and surgery experimental experience and interest in the areas of tissue regeneration is sought to participate in the NIH and DOD funded projects. The Lab particularly emphasizes development of multidisciplinary and novel approaches to address relevant biomedical questions in musculoskeletal tissue applications. Highly motivated candidates with experimental background, strong academic and publication record, and the ability to work independently and collaboratively with a strong commitment are invited to apply. Interested candidates should send a cover letter, their CV, and the names and contact information of three references electronically to the email address given below, ypyang@stanford.edu. The positions are open immediately.

    Qualifications:

    The postdoctoral fellow will participate in the projects involving stem cells and requires a strong background in stem cell biology, bone biology, genetic editing and surgical skills in orthopedic trauma and tendon injury in vivo models. The applicants who have abundant experience with cell culture, RNA extraction, qRT-PCR, bioinformatic analysis, tissue analysis techniques, such as paraffin embedding, tissue sectioning, immunohistological staining, histomorphometry, micro-CT, and mechanical tests, and orthopaedic surgery for rodents are highly encouraged for application.

  • 7 Jul 2020 9:00 AM | Anonymous


    The first Impact Factor of Bioactive Materials was released and the journal achieved an impact factor of 8.724. It ranks 2nd out of 38 journals in Materials Science, Biomaterials category and 5th out of 87 journals in Engineering, Biomedical category. Bioactive Materials is an international, peer-reviewed research publication covering all aspects of bioactive materials (http://www.keaipublishing.com/en/journals/bioactive-materials/). Congratulations to all editorial board members!

  • 18 May 2020 9:00 AM | Anonymous

    Dr. Hu Yang will begin his new role as the chair of the chemical and biochemical engineering department at Missouri S&T on 8/1/2020. Yang joins Missouri S&T from Virginia Commonwealth University (VCU) where he is the Qimonda Endowed Chair in chemical and life science engineering, biomedical engineering, and pharmaceutics. Congratulations! 

    Source:  Missouri S&T

  • 7 May 2020 9:00 AM | Anonymous

    We are pleased to announce the winners of the CAB Awards in 2020! The CAB Global Biomaterials Leadership Award is awarded to Prof. Kam W Leong and Prof. David L. Kaplan to recognize their distinguished leadership in advancing the basic and translational research in biomaterials. The CAB Mid-Career, Young Investigator, and Trainee Awards go to Prof. Jingwei Xie, Prof. Yi Hong, Prof. Y. Shrike Zhang, Prof. Eun Ji Chung, Dr. Xuehui Zhang, Dr. Peng Shi, and Dr. Guomin Wang, respectively, for their excellent achievements in biomaterials research. Please join us to congratulate all the CAB award winners!

    CAB Global Biomaterials Leadership Award

    Prof. Kam W Leong (Columbia University)

    Prof. David L. Kaplan (Tufts University)

    CAB Mid-Career Award

    Prof. Jingwei Xie (University of Nebraska Medical Center)

    Prof. Yi Hong (University of Texas at Arlington)

    CAB Young Investigator Award

    Prof. Y. Shrike Zhang (Harvard Medical School)

    Prof. Eun Ji Chung (University of Southern California)

    CAB Trainee Award

    Dr. Xuehui Zhang (Peking University School and Hospital of Stomatology)

    Dr. Peng Shi (The Pennsylvania State University)

    Dr. Guomin Wang (City University of Hong Kong)


    Biography of awardees


  • 14 Feb 2020 5:00 PM | Anonymous

    Sepsis, a severe condition caused by infections, affects millions of people worldwide every year and remains the leading cause of death in hospitals. In addition, multidrug-resistant (MDR) bacteria have become an additional challenge in the treatment of sepsis and thus, effective therapeutics are urgently needed. A recent paper from Dr. Yizhou Dong and his collaborators at The Ohio State University reported a novel approach for overcoming MDR bacteria-induced sepsis that combines vitamin derived lipid nanoparticles with adoptive macrophage therapy. In this study, the adoptive transfer of macrophages containing antimicrobial peptides in the lysosomes (MACs) reduced bacterial burden and improve survival in the sepsis mouse models. This work was published in Nature Nanotechnology (https://www.nature.com/articles/s41565-019-0600-1).


  • 14 Feb 2020 8:00 AM | Anonymous

    Cell replacement therapy such as intrahepatic transplantation of donor islets is relatively successful for type 1 diabetes in some patients. However, there are a number of limitations including immediate blood-mediated inflammatory response, potential risks of thrombosis and localized steatosis, and inability to retrieve or replace failed cells. Subcutaneous site is less invasive and easier-to-access but lacks sufficient vasculature to support the islet function. Dr. Minglin Ma and his collaborators reported a pre-vascularized islet construct that functioned in the subcutaneous site and corrected diabetes in mice for 3 months. (https://doi.org/10.1038/s41467-019-12373-5)


  • 12 Feb 2020 8:00 AM | Anonymous

    Glucose-responsive insulin delivery systems that mimic pancreatic endocrine function could enhance health and improve quality of life for people with type 1 and type 2 diabetes with reduced β-cell function. Recently, a research team led by Zhen Gu, a professor of bioengineering at the UCLA Samueli School of Engineering and a member of CAB, developed a smart insulin-delivery patch that could one day monitor and manage glucose levels in people with diabetes and deliver necessary insulin dosage. In the experiments, one quarter-sized patch successfully controlled glucose levels in pigs (> 25 kg) with type I diabetes for about 20 hours. A study describing the research in which the patch was published in Nature Biomedical Engineering (https://doi.org/10.1038/s41551-019-0508-y).

<< First  < Prev   1   2   Next >  Last >> 

CAB is a non-profit organization.

Powered by Wild Apricot Membership Software